The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...

Since announcing her multiple sclerosis diagnosis in 2018, Selma Blair has been an outspoken advocate for people with MS. The ...

MNDs are neurological disorders that destroy motor neurons, the cells that control skeletal muscle activity such as walking, breathing, speaking, and swallowing.

Earlier clearance enabled Neurophet‘s software to analyze brain atrophy using T1-weighed MRI scans ... due to multiple sclerosis (MS). These star-shaped cells of the brain and spinal cord ...

Having presented new data at last year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS ... around nerves in the brain and spinal cord, damaging the myelin and ...

Background Leber's hereditary optic neuropathy (LHON) and a multiple sclerosis (MS ... of the 2010 revision to McDonald's MRI criteria regarding ‘dissemination in space’, to take into account the lack ...

Our newest Australian of the Year, Neale Daniher, was diagnosed with motorneurone disease – MND – in 2013 and his condition ...

Roche announces positive results from EMBARK phase III study of Elevidys in ambulatory individuals with DMD: Basel Tuesday, January 28, 2025, 11:00 Hrs [IST] Roche announced posit ...

Roche has reported positive results from the second year of the EMBARK Phase III trial of Elevidys (delandistrogene moxeparvovec), the first approv ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

MRI is a key modality for assessing multiple sclerosis (MS) disease course and response to treatment. Current conventional MRI is limited by repositioning error, and methods of quantifying lesion ...